Skip to content

The effect of oral nutrition supplement (ONS) on autologous hematopoietic stem cell transplantation

The effect of oral nutrition supplement (ONS) on nutritional and clinical status of patients undergoing autologous hematopoietic stem cell transplantation

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220208053971N2
Enrollment
38
Registered
2022-12-09
Start date
2022-12-17
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Lymphoma. Condition 2: multiple myeloma. Non-Hodgkin lymphoma, unspecified Multiple myeloma

Interventions

Intervention 1: Intervention group: The type of intervention in the treatment group will be an oral nutritional supplement of 500 kcal, including carbohydrates, fat, protein, vitamins, and minerals. T

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with lymphoma or multiple myeloma are candidates for autologous hematopoietic stem cell transplantation Age range 18-50 years

Exclusion criteria

Exclusion criteria: Reluctance to cooperate

Design outcomes

Primary

MeasureTime frame
Weight. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Seca Scales.;Body mass index(BMI). Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Questionnaire and calculation.

Secondary

MeasureTime frame
Appetite. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Visual analog scale.;Hand grip strength. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Hand dynamometer.;Mid-arm circumference. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Seca tape measure.;Calf circumference. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Seca tape measure.;Total energy intake. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Food record questionnaire & Analysis by N4 software.;Protein intake. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: Food record questionnaire & Analysis by N4 software.;Carbohydrate intake. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measurement: food record questionnaire & Analysis by N4 software.;Fat intake. Timepoint: The first stage, on the negative day 7 of transplantation, the second stage, positive 14 days after transplantation, and the third stage, 90 days after transplantation. Method of measuremen

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hamed Mohammadi

Tehran University of Medical Sciences

mohamadihd@gmail.com0098 21 889900285

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026